Garheng Kong

Garheng serves as Chairman of the Board of Ajax Health. A physician, scientist, and engineer by training, Garheng has over two decades of experience investing in innovative companies in all areas of healthcare, and has led over 25 companies to successful exits (IPO and M&A).

Garheng is the Founder and Managing Partner of HealthQuest Capital, a private asset firm that currently provides growth capital to transformative companies that are improving value in the healthcare system. HealthQuest Capital has a longstanding capital partnership with Ajax Health, having first invested in Spirox (led by Duke Rohlen and sold to Entellus), and subsequently in all Ajax-backed companies. Prior to founding HealthQuest, Garheng was a partner at Intersouth Partners and Sofinnova Investments, and has also spent time at GlaxoSmithKline and McKinsey, and as a CEO of two early-stage biotech companies.

Garheng also serves on boards of LabCorp (LH), Alimera Sciences (ALIM), StrongBridge (SBBP), Be The Match, and the Duke University Medical Center. He is an Aspen Institute Health Innovators Fellow, Kauffman Fellows Mentor, and member of YPO.

Garheng received undergraduate degrees in both Chemical Engineering and Biological Sciences from Stanford, while on an athletic scholarship, and earned MD, PhD and MBA degrees from Duke University.